In some cases, maternal antibodies can contribute to neonatal disorders. For example, in hemolytic disease of the newborn (HDN), maternal antibodies target the infant's red blood cells, leading to hemolysis and anemia. Another example is neonatal alloimmune thrombocytopenia (NAIT), where maternal antibodies attack the infant's platelets, causing a low platelet count and an increased risk of bleeding.
